NYSE - Nasdaq Real Time Price USD

Teleflex Incorporated (TFX)

211.11 +3.84 (+1.85%)
At close: April 23 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,974,489.00
2,974,489.00
2,791,041.00
2,809,563.00
2,537,156.00
Cost of Revenue
1,327,558.00
1,327,558.00
1,259,954.00
1,259,961.00
1,212,282.00
Gross Profit
1,646,931.00
1,646,931.00
1,531,087.00
1,549,602.00
1,324,874.00
Operating Expense
1,084,218.00
1,084,218.00
1,017,567.00
990,926.00
863,315.00
Operating Income
562,713.00
562,713.00
513,520.00
558,676.00
461,559.00
Net Non Operating Interest Income Expense
-72,301.00
-72,301.00
-53,352.00
-55,641.00
-65,336.00
Other Income Expense
-56,400.00
-56,400.00
-14,249.00
56,433.00
-38,491.00
Pretax Income
434,012.00
434,012.00
445,919.00
559,468.00
357,732.00
Tax Provision
76,440.00
76,440.00
83,003.00
74,349.00
21,931.00
Net Income Common Stockholders
356,328.00
356,328.00
363,139.00
485,374.00
335,324.00
Diluted NI Available to Com Stockholders
356,328.00
356,328.00
363,139.00
485,374.00
335,324.00
Basic EPS
8.59
7.58
7.74
10.38
7.21
Diluted EPS
8.55
7.53
7.68
10.23
7.09
Basic Average Shares
46,958.00
46,981.00
46,898.00
46,774.00
46,488.00
Diluted Average Shares
47,284.25
47,304.00
47,309.00
47,427.00
47,287.00
Total Operating Income as Reported
506,313.00
506,313.00
499,725.00
628,095.00
423,068.00
Total Expenses
2,411,776.00
2,411,776.00
2,277,521.00
2,250,887.00
2,075,597.00
Net Income from Continuing & Discontinued Operation
356,328.00
356,328.00
363,139.00
485,374.00
335,324.00
Normalized Income
404,045.60
404,045.60
374,514.69
436,191.59
371,944.05
Interest Income
12,781.00
12,781.00
912.00
1,328.00
1,158.00
Interest Expense
85,082.00
85,082.00
54,264.00
56,969.00
66,494.00
Net Interest Income
-72,301.00
-72,301.00
-53,352.00
-55,641.00
-65,336.00
EBIT
519,094.00
519,094.00
500,183.00
616,437.00
424,226.00
EBITDA
761,212.00
761,212.00
730,773.00
853,799.00
651,478.00
Reconciled Cost of Revenue
1,327,558.00
1,327,558.00
1,259,954.00
1,259,961.00
1,212,282.00
Reconciled Depreciation
242,118.00
242,118.00
230,590.00
237,362.00
227,252.00
Net Income from Continuing Operation Net Minority Interest
357,572.00
357,572.00
362,916.00
485,119.00
335,801.00
Total Unusual Items Excluding Goodwill
-56,400.00
-56,400.00
-14,249.00
56,433.00
-38,491.00
Total Unusual Items
-56,400.00
-56,400.00
-14,249.00
56,433.00
-38,491.00
Normalized EBITDA
817,612.00
817,612.00
745,022.00
797,366.00
689,969.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-9,926.40
-9,926.40
-2,650.31
7,505.59
-2,347.95
12/31/2020 - 3/17/1980

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

COO The Cooper Companies, Inc.
91.68
+1.82%
 
XRAY DENTSPLY SIRONA Inc.
30.86
+1.61%
 
ICUI ICU Medical, Inc.
97.76
+1.43%
 
ANGO AngioDynamics, Inc.
6.03
-3.67%
 
HAE Haemonetics Corporation
85.07
+1.73%
 
UTMD Utah Medical Products, Inc.
67.56
-0.84%
 
WST West Pharmaceutical Services, Inc.
390.20
+4.01%
 
ATR AptarGroup, Inc.
140.15
-0.12%
 
HOLX Hologic, Inc.
77.19
+1.27%
 
MMSI Merit Medical Systems, Inc.
74.18
+1.27%